Galapagos NV 2024 SR
The report outlines Galapagos' sustainability strategy 'Forward, Sustainably,' focusing on patient outcomes, environmental health, and employee well-being. Key highlights for 2024 include the transfer of the Jyseleca business to Alfasigma and the establishment of a 2028 roadmap for low-carbon transition. The company conducted a double materiality assessment in accordance with ESRS and reported a 59% renewable energy share. Additionally, Galapagos emphasized patient engagement through its Patient Partnership Charter and strengthened its R&D pipeline in oncology and immunology, committing to a net-zero target by 2040.
Company: Galapagos NV
Sector: Health Care
Country: Belgium
Year: 2024
Type: SR
Pages: 43
Galapagos NV
Sustainability Statements
The report outlines Galapagos' sustainability strategy 'Forward, Sustainably,' focusing on patient outcomes, environmental health, and employee well-being. Key highlights for 2024 include the transfer of the Jyseleca business to Alfasigma and the establishment of a 2028 roadmap for low-carbon transition. The company conducted a double materiality assessment in accordance with ESRS and reported a 59% renewable energy share. Additionally, Galapagos emphasized patient engagement through its Patient Partnership Charter and strengthened its R&D pipeline in oncology and immunology, committing to a net-zero target by 2040.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Net Zero Target
Employees